Latest Regulatory News

The Takeovers Panel has directed Emu NL and its former directors to cover a combined $41,712 in costs incurred by Wayburn Holdings during takeover proceedings, underscoring ongoing regulatory scrutiny.

Pro Medicus has disclosed a contained data breach involving unauthorized access to a single employee email inbox, with limited exposure of personal information from around 100 current and former employees.

Volt Resources has initiated a Definitive Feasibility Study for its Alabama Graphite Refinery, aiming to produce high purity graphite by mid-2026 and strengthen US critical minerals supply chains.

Chariot Resources has confirmed high-grade lithium mineralisation at its Fonlo and Iganna projects in Nigeria, with assays returning up to 5.96% lithium oxide. The results reinforce the potential for near-term production and resource expansion within its Nigerian lithium portfolio.

Global Lithium Resources has released a Definitive Feasibility Study for its Manna Lithium Project, confirming robust financials and a long mine life in Western Australia. The study sets the stage for a Final Investment Decision in 2026 amid improving lithium market conditions.

InhaleRx has boosted its funding facility by $12.6 million to accelerate clinical trials of SRX-25, a novel oral treatment for Treatment-Resistant Depression. This brings total available capital to $52.3 million, positioning the company for pivotal Phase III studies.

Savannah Goldfields has poured nearly 7kg of doré at its Georgetown Gold Processing Plant, marking steady progress in gold production and setting the stage for upcoming mining at Big Reef and Agate Creek.

St George Mining’s Araxá Project in Brazil gains significant government and community support, highlighting its potential as a world-class rare earths and niobium resource with sustainable mining at its core.

APC Minerals Limited has initiated a fully underwritten pro-rata renounceable entitlement offer to raise approximately $1.38 million at $0.004 per share, aiming to fund its exploration projects and working capital needs.

Pacgold has finalized its acquisition of the White Dam Gold Operation in South Australia, setting the stage for a near-term production restart with modest capital investment. The move complements its Queensland projects and offers a clear path to cash flow.

Neurizon Therapeutics has completed manufacturing three GMP registration batches of its lead ALS drug candidate NUZ-001 ahead of schedule, paving the way for FDA submissions and clinical trial enrollment.

Island Pharmaceuticals has submitted critical responses to the FDA, advancing the development of its antiviral Galidesivir under the Animal Rule pathway. The company awaits FDA feedback expected by early January 2026, setting the stage for upcoming Marburg virus studies.